Compound Detail
CHEMBL5826084
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5826084 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PPCNFXQXVGAXIF-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
431.5
MW (Da)
3.76
ALogP
7
HBA
2
HBD
88.0
PSA (Ų)
0.64
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 8.62 | 8.62 | 2.4 | 1 |
| Cyclin-dependent kinase 6 CHEMBL2508 | IC50 | 7.51 | 7.51 | 30.6 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Cyclin-dependent kinase 4 | IC50 | = | 2.37 | nM | 8.62 | Inhibition Assay: LANCE method of PerkinElmer Inc. was used in the assay, and re... | - |
| Cyclin-dependent kinase 6 | IC50 | = | 30.6 | nM | 7.51 | Inhibition Assay: LANCE method of PerkinElmer Inc. was used in the assay, and re... | - |
Data from ChEMBL 36 via Core Engine